The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline,New Onset Cognitive Impairment,and Incident Dementia: A Systematic Review and Conceptual Model for Future Research
Restricted accessResearch articleFirst published online November 24, 2020
The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline,New Onset Cognitive Impairment,and Incident Dementia: A Systematic Review and Conceptual Model for Future Research
Growing evidence suggests that chronic pain and certain chronic pain conditions may increase risk for cognitive decline and dementia.
Objective:
In this systematic review, we critically evaluate available evidence regarding the association of chronic pain and specific common chronic pain conditions to subsequent decline in cognitive function, new onset cognitive impairment (CI), and incident Alzheimer’s disease and related dementias (ADRD); outline major gaps in the literature; and provide a preliminary conceptual model illustrating potential pathways linking pain to cognitive change.
Methods:
To identify qualifying studies, we searched seven scientific databases and scanned bibliographies of identified articles and relevant review papers. Sixteen studies met our inclusion criteria (2 matched case-control, 10 retrospective cohort, 2 prospective cohort), including 11 regarding the association of osteoarthritis (N = 4), fibromyalgia (N = 1), or headache/migraine (N = 6) to incident ADRD (N = 10) and/or its subtypes (N = 6), and 5 investigating the relation of chronic pain symptoms to subsequent cognitive decline (N = 2), CI (N = 1), and/or ADRD (N = 3).
Results:
Studies yielded consistent evidence for a positive association of osteoarthritis and migraines/headaches to incident ADRD; however, findings regarding dementia subtypes were mixed. Emerging evidence also suggests chronic pain symptoms may accelerate cognitive decline and increase risk for memory impairment and ADRD, although findings and measures varied considerably across studies.
Conclusion:
While existing studies support a link between chronic pain and ADRD risk, conclusions are limited by substantial study heterogeneity, limited investigation of certain pain conditions, and methodological and other concerns characterizing most investigations to date. Additional rigorous, long-term prospective studies are needed to elucidate the effects of chronic pain and specific chronic pain conditions on cognitive decline and conversion to ADRD, and to clarify the influence of potential confounding and mediating factors.
AbubakarI, TillmannT, BanerjeeA (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet385, 117–171.
2.
FeiginVL, AbajobirAA, AbateKH, Abd-AllahF, AbdulleAM, AberaSF, AbyuGY, AhmedMB, AichourAN, AichourI (2017) Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol16, 877–897.
3.
Alzheimer’s Association (2019) 2019 Alzheimer’s disease facts and figures. Alzheimers Dement15, 321–387.
4.
WinbladB, AmouyelP, AndrieuS, BallardC, BrayneC, BrodatyH, Cedazo-MinguezA, DuboisB, EdvardssonD, FeldmanH, FratiglioniL, FrisoniGB, GauthierS, GeorgesJ, GraffC, IqbalK, JessenF, JohanssonG, JonssonL, KivipeltoM, KnappM, MangialascheF, MelisR, NordbergA, RikkertMO, QiuC, SakmarTP, ScheltensP, SchneiderLS, SperlingR, TjernbergLO, WaldemarG, WimoA, ZetterbergH (2016) Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol15, 455–532.
5.
VerlindenVJ, van der GeestJN, de BruijnRF, HofmanA, KoudstaalPJ, IkramMA (2016) Trajectories of decline in cognition and daily functioning in preclinical dementia. Alzheimers Dement12, 144–153.
6.
PickettJ, BirdC, BallardC, BanerjeeS, BrayneC, CowanK, ClareL, Comas-HerreraA, CornerL, DaleyS, KnappM, LafortuneL, LivingstonG, ManthorpeJ, MarchantN, MoriartyJ, RobinsonL, van LyndenC, WindleG, WoodsB, GrayK, WaltonC (2018) A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. Int J Geriatr Psychiatry33, 900–906.
7.
KulmalaJ, NganduT, KivipeltoM (2018) Prevention matters: Time for global action and effective implementation. J Alzheimer’s Dis64, S191–S198.
8.
ImtiazB, TolppanenAM, KivipeltoM, SoininenH (2014) Future directions in Alzheimers disease from risk factors to prevention. Biochem Pharmacol88, 661–670.
9.
KivipeltoM, MangialascheF, NganduT (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol14, 653–666.
10.
BrodatyH, HeffernanM, Fiatarone SinghMA, ValenzuelaM, AndrewsG, LautenschlagerNT, AnsteyKJ, MaederA, JormLR, McNeilJ (2017) Maintain your brain: A randomised controlled trial of an internet-based multi-comonent lifestyle intervention to prevent cognitive decline and dementia.Alzheimers Dement13, P1216–P1216.
11.
RitchieCW, MolinuevoJL, TruyenL, SatlinA, Van der GeytenS, LovestoneS, European Prevention of Alzheimer’s Dementia Consortium (2016) Development of interventions for the secondary prevention of Alzheimer’s dementia: The European Prevention of Alzheimer’s Dementia (EPAD) project. Lancet Psychiatry3, 179–186.
12.
BottN, KumarS, KrebsC, GlennJM, MaderoEN, JuusolaJL (2018) A remote intervention to prevent or delay cognitive impairment in older adults: Design, recruitment, and baseline characteristics of the Virtual Cognitive Health (VC Health) Study. JMIR Res Protoc7, e11368.
13.
MangialascheF, KivipeltoM, SolomonA, FratiglioniL (2012) Dementia prevention: Current epidemiological evidence and future perspective. Alzheimers Res Ther4, 6.
14.
RasmussenKL, Tybjarg-HansenA, NordestgaardBG, Frikke-SchmidtR (2018) Absolute 10-year risk of dementia by age, sex and APOE genotype: A population-based cohort study. CMAJ190, E1033–E1041.
15.
MillsSEE, NicolsonKP, SmithBH (2019) Chronic pain: A review of its eidemiology and associated factors in population-based studies.Br J Anaesth123, e273–e283.
16.
LeeY, BackJH, KimJ, ByeonH (2010) Multiple socioeconomic risks and cognitive impairment in older adults. Dement Geriatr Cogn Disord29, 523–529.
17.
MengX, D’ArcyC (2012) Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses. PLoS One7, e38268.
18.
LeistAK, GlymourMM, MackenbachJP, van LentheFJ, AvendanoM (2013) Time away from work predicts later cognitive function: Differences by activity during leave. Ann Epidemiol23, 455–462.
19.
LiG, ShenYC, ChenCH, ZhauYW, LiSR, LuM (1991) A three-year follow-up study of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand83, 99–104.
20.
BaumgartM, SnyderHM, CarrilloMC, FazioS, KimH, JohnsH (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement11, 718–726.
21.
ZhongG, WangY, ZhangY, GuoJJ, ZhaoY (2015) Smoking is associated with an increased risk of dementia: A meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One10, e0118333.
22.
CaoL, TanL, WangH-F, JiangT, ZhuX-C, LuH, TanM-S, YuJ-T (2016) Dietary patterns and risk of dementia: A systematic review and meta-analysis of cohort studies. Mol Neurobiol53, 6144–6154.
23.
MayerF, Di PucchioA, LacorteE, BacigalupoI, MarzoliniF, FerranteG, MinardiV, MasoccoM, CanevelliM, Di FiandraT, VanacoreN (2018) An estimate of attributable cases of Alzheimer disease and vascular dementia due to modifiable risk factors: The impact of primary prevention in Europe and in Italy. Dement Geriatr Cogn Dis Extra8, 60–71.
24.
NortonS, MatthewsFE, BarnesDE, YaffeK, BrayneC (2014) Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol13, 788–794.
25.
KuiperJS, ZuidersmaM, Oude VoshaarRC, ZuidemaSU, van den HeuvelER, StolkRP, SmidtN (2015) Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev22, 39–57.
26.
ZhaoC, NobleJM, MarderK, HartmanJS, GuY, ScarmeasN (2018) Dietary patterns, physical activity, sleep, and risk for dementia and cognitive decline. Curr Nutr Rep7, 335–345.
27.
MortimerJA, SternY (2019) Physical exercise and activity may be important in reducing dementia risk at any age. Neurology92, 362–363.
28.
NguyenJCD, KillcrossAS, JenkinsTA (2014) Obesity and cognitive decline: Role of inflammation and vascular changes. Front Neurosci8, 375.
29.
SellbomKS, GunstadJ (2012) Cognitive function and decline in obesity. J Alzheimers Dis30(Suppl 2), S89–95.
30.
MortamaisM, AbdennourM, BerguaV, TzourioC, BerrC, GabelleA, AkbaralyTN (2018) Anxiety and 10-year risk of incident dementia-an association shaped by depressive symptoms: Results of the Prospective Three-City Study. Front Neurosci12, 248.
31.
FordE, GreensladeN, PaudyalP, BremnerS, SmithHE, BanerjeeS, SadhwaniS, RooneyP, OliverS, CassellJ (2018) Predicting dementia from primary care records: A systematic review and meta-analysis. PLoS One13, e0194735.
32.
CherbuinN, KimS, AnsteyKJ (2015) Dementia risk estimates associated with measures of depression: A systematic review and meta-analysis. BMJ Open5, e008853.
33.
MouraoRJ, MansurG, Malloy-DinizLF, Castro CostaE, DinizBS (2016) Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta-analysis. Int J Geriatr Psychiatry31, 905–911.
34.
GallagherD, KissA, LanctotK, HerrmannN (2016) Depressive symptoms and cognitive decline: A longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. J Affect Disord190, 235–240.
35.
GulpersB, RamakersI, HamelR, KohlerS, Oude VoshaarR, VerheyF (2016) Anxiety as a predictor for cognitive decline and dementia: A systematic review and meta-analysis. Am J Geriatr Psychiatry24, 823–842.
36.
PetkusAJ, ReynoldsCA, WetherellJL, KremenWS, PedersenNL, GatzM (2016) Anxiety is associated with increased risk of dementia in older Swedish twins. Alzheimers Dement12, 399–406.
37.
YaffeK, VittinghoffE, LindquistK, BarnesD, CovinskyKE, NeylanT, KluseM, MarmarC (2010) Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry67, 608–613.
38.
MawandaF, WallaceRB, McCoyK, AbramsTE (2017) PTSD, psychotropic medication use, and the risk of dementia among US veterans: A retrospective cohort study. J Am Geriatr Soc65, 1043–1050.
39.
FlattJD, GilsanzP, QuesenberryCPJr, AlbersKB, WhitmerRA (2018) Post-traumatic stress disorder and risk of dementia among members of a health care delivery system. Alzheimers Dement14, 28–34.
40.
JohanssonL, GuoXX, WaernM, OstlingS, GustafsonD, BengtssonC, SkoogI (2010) Midlife psychological stress and risk of dementia: A 35-year longitudinal population study. Brain133, 2217–2224.
41.
KessingLV, NilssonFM (2003) Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord73, 261–269.
42.
ShiL, ChenSJ, MaMY, BaoYP, HanY, WangYM, ShiJ, VitielloMV, LuL (2018) Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev40, 4–16.
43.
FannJR, RibeAR, PedersenHS, Fenger-GronM, ChristensenJ, BenrosME, VestergaardM (2018) Long-term risk of dementia among people with traumatic brain injury in Denmark: A population-based observational cohort study. Lancet Psychiatry5, 424–431.
44.
NordstromA, NordstromP (2018) Traumatic brain injury and the risk of dementia diagnosis: A nationwide cohort study. PLoS Med15, e1002496.
45.
LiY, LiY, LiX, ZhangS, ZhaoJ, ZhuX, TianG (2017) Head injury as a risk factor for dementia and Alzheimer’s disease: A systematic review and meta-analysis of 32 observational studies. PLoS One12, e0169650.
46.
PalK, MukadamN, PetersenI, CooperC (2018) Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: A systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol53, 1149–1160.
47.
BiesselsGJ, DespaF (2018) Cognitive decline and dementia in diabetes mellitus: Mechanisms and clinical implications. Nat Rev Endocrinol14, 591–604.
48.
QiuC, FratiglioniL (2015) A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol12, 267–277.
49.
AdelborgK, Horvath-PuhoE, OrdingA, PedersenL, Toft SorensenH, HendersonVW (2017) Heart failure and risk of dementia: A Danish nationwide population-based cohort study. Eur J Heart Fail19, 253–260.
50.
KakkeraK, PadalaKP, KodaliM, PadalaPR (2018) Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia. Curr Opin Pulm Med24, 173–178.
51.
VassilakiM, AakreJA, ChaRH, KremersWK, St SauverJL, MielkeMM, GedaYE, MachuldaMM, KnopmanDS, PetersenRC, RobertsRO (2015) Multimorbidity and risk of mild cognitive impairment. J Am Geriatr Soc63, 1783–1790.
52.
FabbriE, AnY, ZoliM, TanakaT, SimonsickEM, Kitner-TrioloMH, StudenskiSA, ResnickSM, FerrucciL (2016) Association of accelerated multi-morbidity and age-related cognitive decline in older, non-demented participants from the Baltimore longitudinal study of aging. J Am Geriatr Soc64, 965–972.
53.
PolyTN, IslamMM, WaltherBA, YangH-C, WuC-C, LinM-C, LiY-C (2020) Association between use of statin and risk of dementia: A meta-analysis of observational studies. Neuroepidemiology54, 214–226.
54.
ChuC-S, TsengP-T, StubbsB, ChenT-Y, TangC-H, LiD-J, YangW-C, ChenY-W, WuC-K, VeroneseN (2018) Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis. Sci Rep8, 1–12.
55.
BellouV, BelbasisL, TzoulakiI, MiddletonLT, IoannidisJPA, EvangelouE (2017) Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement13, 406–418.
56.
IslamMM, IqbalU, WaltherB, AtiqueS, DubeyNK, NguyenPA, PolyTN, MasudJHB, LiYC, ShabbirSA (2016) Benzodiazepine use and risk of dementia in the elderly population: A systematic review and meta-analysis. Neuroepidemiology47, 181–191.
57.
BaekYH, LeeH, KimWJ, ChungJE, PrattN, EllettLK, ShinJY (2020) Uncertain association between benzodiazepine use and the risk of dementia: A cohort study. J Am Med Dir Assoc21, 201–211.e202.
58.
RichardsonK, MattishentK, LokeYK, SteelN, FoxC, GrossiCM, BennettK, MaidmentI, BoustaniM, MatthewsFE, MyintPK, CampbellNL, BrayneC, RobinsonL, SavvaGM (2019) History of benzodiazepine prescriptions and risk of dementia: Possible bias due to prevalent users and covariate measurement timing in a nested case-control study. Am J Epidemiol188, 1228–1236.
59.
VetranoDL, VillaniER, GrandeG, GiovanniniS, CiprianiMC, Manes-GravinaE, BernabeiR, OnderG (2018) Association of polypharmacy with 1-year trajectories of cognitive and physical function in nursing home residents: Results from a multicenter European study. J Am Med Dir Assoc19, 710–713.
60.
ParkH-Y, ParkJ-W, SongHJ, SohnHS, KwonJ-W (2017) The association between polypharmacy and dementia: A nested case-control study based on a 12-year longitudinal cohort database in South Korea. PLoS One12, e0169463.
61.
LeelakanokN, D’CunhaRR (2019) Association between polypharmacy and dementia–A systematic review and metaanalysis. Aging Ment Health23, 932–941.
62.
Arthritis Foundation (2019) Arthritis by the numbers- book of trusted facts & figures. Arthritis Foundation3, 1–100.
63.
MaieseK (2016) Picking a bone with WISP1 (CCN4): New strategies against degenerative joint disease. J Transl Sci1, 83–85.
64.
HiligsmannM, CooperC, ArdenN, BoersM, BrancoJC, Luisa BrandiM, BruyereO, GuilleminF, HochbergMC, HunterDJ, KanisJA, KvienTK, LaslopA, PelletierJ-P, PintoD, Reiter-NiesertS, RizzoliR, RovatiLC, SeverensJLH, SilvermanS, TsouderosY, TugwellP, ReginsterJ-Y (2013) Health economics in the field of osteoarthritis: An expert’s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum43, 303–313.
65.
CrossM, SmithE, HoyD, NolteS, AckermanI, FransenM, BridgettL, WilliamsS, GuilleminF, HillCL, LaslettLL, JonesG, CicuttiniF, OsborneR, VosT, BuchbinderR, WoolfA, MarchL (2014) The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis73, 1323–1330.
66.
DomenichielloAF, RamsdenCE (2019) The silent epidemic of chronic pain in older adults. Prog Neuropsychopharmacol Biol Psychiatry93, 284–290.
67.
DahlhamerJ, LucasJ, ZelayaC, NahinR, MackeyS, DeBarL, KernsR, Von KorffM, PorterL, HelmickC (2018) Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR67, 1001–1006.
68.
DornerTE (2018) Pain and chronic pain epidemiology: Implications for clinical and public health fields. Wien Klin Wochenschr130, 1–3.
69.
JohannesCB, LeTK, ZhouX, JohnstonJA, DworkinRH (2010) The prevalence of chronic pain in United States adults: Results of an Internet-based survey. J Pain11, 1230–1239.
70.
TsangA, Von KorffM, LeeS, AlonsoJ, KaramE, AngermeyerMC, BorgesGLG, BrometEJ, DemytteneareK, de GirolamoG, de GraafR, GurejeO, LepineJ-P, HaroJM, LevinsonD, Oakley BrowneMA, Posada-VillaJ, SeedatS, WatanabeM (2008) Common chronic pain conditions in developed and developing countries: Gender and age differences and comorbidity with depression-anxiety disorders. J Pain9, 883–891.
71.
NahinRL, SayerB, StussmanBJ, FeinbergTM (2019) Eighteen-year trends in the prevalence of, and health care use for, noncancer pain in the United States: Data from the Medical Expenditure Panel Survey. J Pain20, 796–809.
72.
FayazA, CroftP, LangfordRM, DonaldsonLJ, JonesGT (2016) Prevalence of chronic pain in the UK: A systematic review and meta-analysis of population studies. BMJ Open6, e010364.
73.
HenschkeN, KamperSJ, MaherCG (2015) The epidemiology and economic consequences of pain. Mayo Clinic Proc90, 139–147.
74.
GaskinDJ, RichardP (2012) The economic costs of pain in the United States. J Pain13, 715–724.
75.
ChinnS, ChuangE, GritsenkoK (2017) Epidemiology. In Pain Medicine: An Essential Review,
YongRJ,
NguyenM,
NelsonE,
UrmanRD, eds. Springer, Switzerland, pp. 27–29.
76.
MoriartyO, McGuireBE, FinnDP (2011) The effect of pain on cognitive function: A review of clinical and preclinical research. Prog Neurobiol93, 385–404.
77.
BreivikH, EisenbergE, O’BrienT, Openminds, AllegriM, JakschW, KressH, SimpsonK, ZyliczZ (2013) The individual and societal burden of chronic pain in Europe: The case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health13, 1229.
78.
PatelAS, FarquharsonR, CarrollD, MooreA, PhillipsCJ, TaylorRS, BardenJ (2012) The impact and burden of chronic pain in the workplace: A qualitative systematic review. Pain Pract12, 578–589.
79.
GBD 2013 DALYs and HALE Collaborators, MurrayCJ, BarberRM, ForemanKJ, Abbasoglu OzgorenA, Abd-AllahF, AberaSF, AboyansV, AbrahamJP, AbubakarI, et al. (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition. Lancet386, 2145–2191.
80.
SeminowiczDA, CekoM (2015) Can we exploit cognitive brain networks to treat chronic pain?Pain Manag5, 399–402.
81.
ApkarianAV, HashmiJA, BalikiMN (2011) Pain and the brain: Specificity and plasticity of the brain in clinical chronic pain. Pain152, S49–S64.
InnesKE, SambamoorthiU (2018) The association of perceived memory loss with osteoarthritis and related joint pain in a large Appalachian population. Pain Med9, 1340–1356.
84.
Vachon-PresseauE, RoyM, MartelM-O, CaronE, MarinM-F, ChenJ, AlbouyG, PlanteI, SullivanMJ, LupienSJ, RainvilleP (2013) The stress model of chronic pain: Evidence from basal cortisol and hippocampal structure and function in humans. Brain136, 815–827.
85.
HigginsDM, MartinAM, BakerDG, VasterlingJJ, RisbroughV (2018) The relationship between chronic pain and neurocognitive function: A systematic review. Clin J Pain34, 262–275.
86.
WangJ-H, WuY-J, TeeBL, LoRY (2018) Medical comorbidity in Alzheimer’s disease: A nested case-control study. J Alzheimers Dis63, 773–781.
87.
HuangS-W, WangW-T, ChouL-C, LiaoC-D, LiouT-H, LinH-W (2015) Osteoarthritis increases the risk of dementia: A nationwide cohort study in Taiwan. Sci Rep5, 10145.
88.
TzengNS, ChungCH, LiuFC, ChiuYH, ChangHA, YehCB, HuangSY, LuRB, YehHW, KaoYC, ChiangWS, TsaoCH, WuYF, ChouYC, LinFH, ChienWC (2018) Fibromyalgia and risk of dementia-a nationwide, population-based, cohort study. Am J Med Sci355, 153–161.
89.
MortonRE, St JohnPD, TyasSL (2019) Migraine and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults. Int J Geriatr Psychiatry34, 1667–1676.
90.
TzengN-S, ChungC-H, LinF-H, YehC-B, HuangS-Y, LuR-B, ChangH-A, KaoY-C, ChiangW-S, ChouY-C, TsaoC-H, WuY-F, ChienW-C (2017) Headaches and risk of dementia. Am J Med Sci353, 197–206.
91.
YangFC, LinTY, ChenHJ, LeeJT, LinCC, KaoCH (2016) Increased risk of dementia in patients with tension-type headache: A nationwide retrospective population-based cohort study. Plos One11, 1–14.
92.
RøtterengAKS, BosnesO, StordalE, ZwartJ-A, LindeM, StovnerLJ, HagenK (2015) Headache as a predictor for dementia: The HUNT Study. J Headache Pain16, 1–7.
93.
ChuangC-S, LinC-L, LinM-C, SungF-C, KaoC-H (2013) Migraine and risk of dementia: A nationwide retrospective cohort study. Neuroepidemiology41, 139–145.
94.
InnesKE, SambamoorthiU (2020) The association of osteoarthritis and related pain burden to incident Alzheimer’s disease and related dementias: A retrospective cohort study of US Medicare beneficiaries. J Alzheimers Dis75, 789–805.
95.
HagenK, StordalE, LindeM, SteinerTJ, ZwartJ-A, StovnerLJ (2014) Headache as a risk factor for dementia: A prospective population-based study. Cephalalgia34, 327–335.
96.
YamadaK, KubotaY, TabuchiT, ShiraiK, IsoH, KondoN, KondoK (2019) A prospective study of knee pain, low back pain, and risk of dementia: The JAGES project. Sci Rep9, 10690.
97.
van der LeeuwG, AyersE, LeveilleSG, BlankensteinAH, van der HorstHE, VergheseJ (2018) The effect of pain on major cognitive impairment in older adults. J Pain19, 1435–1444.
98.
EzzatiA, WangC, KatzMJ, DerbyCA, ZammitAR, ZimmermanME, PavlovicJM, SliwinskiMJ, LiptonRB (2019) The temporal relationship between pain intensity and pain interference and incident dementia. Curr Alzheimer Res16, 109–115.
99.
WhitlockEL, Diaz-RamirezLG, GlymourMM, BoscardinWJ, CovinskyKE, SmithAK (2017) Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern Med177, 1146–1153.
100.
ChenKT, ChenYC, FanYH, LinWX, LinWC, WangYH, LinL, ChiouJY, WeiJC (2018) Rheumatic diseases are associated with a higher risk of dementia: A nation-wide, population-based, case-control study. Int J Rheum Dis21, 373–380.
101.
VeroneseN, KoyanagiA, SolmiM, ThompsonT, MaggiS, SchofieldP, MuellerC, GaleCR, CooperC, StubbsB (2018) Pain is not associated with cognitive decline in older adults: A four-year longitudinal study. Maturitas115, 92–96.
102.
Grol-ProkopczykH (2017) Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain158, 313–322.
103.
KuehnerC (2017) Why is depression more common among women than among men?Lancet Psychiatry4, 146–158.
104.
FlorindoAA, GuimaraesVV, CesarCL, BarrosMB, AlvesMC, GoldbaumM (2009) Epidemiology of leisure, transportation, occupational, and household physical activity: Prevalence and associated factors. J Phys Act Health6, 625–632.
105.
NusselderWJ, CamboisEM, WapperomD, MesleF, LoomanCWN, YokotaRTC, Van OyenH, JaggerC, RobineJM (2019) Women’s excess unhealthy life years: Disentangling the unhealthy life years gap. Eur J Public Health29, 914–919.
106.
NusselderWJ, WapperomD, LoomanCW, et al. (2019) Contribution of chronic diseases to gender differences in activity limitations. Eur J Public Health29, 99–104.
107.
NygårdM, HärtullC, WentjärviA, JungerstamS (2017) Poverty and old age in Scandinavia: A problem of gendered injustice? Evidence from the 2010 GERDA Survey in Finland and Sweden. Soc Indic Res132, 681–698.
108.
ArokeEN, JosephPV, RoyA, OverstreetDS, TollefsbolTO, VanceDE, GoodinBR (2019) Could epigenetics help explain racial disparities in chronic pain?J Pain Res12, 701–710.
109.
NijsJ, D’HondtE, ClarysP, DeliensT, PolliA, MalflietA, CoppietersI, WillaertW, Tumkaya YilmazS, ElmaO, IckmansK (2020) Lifestyle and chronic pain across the lifespan: An inconvenient truth?PM&R12, 410–419.
110.
KarayannisNV, BaumannI, SturgeonJA, MellohM, MackeySC (2019) The impact of social isolation on pain interference: A longitudinal study. Ann Behav Med53, 65–74.
111.
SmithT (2017) “On their own”: Social isolation, loneliness and chronic musculoskeletal pain in older adults. Qual Ageing18, 87–92.
112.
SmithTO, DaintyJR, WilliamsonE, MartinKR (2019) Association between musculoskeletal pain with social isolation and loneliness: Analysis of the English longitudinal study of ageing. Br J Pain13, 82–90.
113.
VowlesKE, McEnteeML, JulnesPS, FroheT, NeyJP, van der GoesDN (2015) Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain156, 569–576.
114.
WitkiewitzK, VowlesKE (2018) Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: A critical review. Alcohol Clin Exp Res42, 478–488.
115.
FishbainDA, ColeB, LewisJE, GaoJ, RosomoffRS (2009) Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med10, 829–839.
116.
YarnellS, LiL, MacGroryB, TrevisanL, KirwinP (2020) Substance use disorders in later life: A review and synthesis of the literature of an emerging public health concern. Am J Ger Psychiatry28, 226–236.
117.
BoakyePA, OlechowskiC, RashiqS, VerrierMJ, KerrB, WitmansM, BakerG, JoyceA, DickBD (2016) A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain32, 327–336.
118.
ShpanerM, TulipaniLJ, BishopJH, NaylorMR (2017) The vicious cycle of chronic pain in aging requires multidisciplinary non-pharmacological approach to treatment. Curr Behav Neurosci Rep4, 176–187.
119.
MantyselkaP, MiettolaJ, NiskanenL, KumpusaloE (2008) Chronic pain, impaired glucose tolerance and diabetes: A community-based study. Pain137, 34–40.
120.
BairMJ, BrizendineEJ, AckermannRT, ShenC, KroenkeK, MarreroDG (2010) Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabet Med27, 578–584.
121.
AbaraoguUO, OchiC, UmahiE, OgbonnayaC, OnahI (2017) Individuals with type 2 diabetes are at higher risk of chronic musculoskeletal pain: A study with diabetes cohort. Int J Diabetes Dev Ctries37, 267–271 .
122.
BruehlS, OlsenRB, TronstadC, SevreK, BurnsJW, SchirmerH, NielsenCS, StubhaugA, RosselandLA (2018) Chronic pain-related changes in cardiovascular regulation and impact on comorbid hypertension in a general population: The Tromso study. Pain159, 119–127.
123.
LinKT, LaiSW, HsuSD, FanCY, WangHJ, ChangPK, LiuW-H, ChenY-L, YenI-C, LeeS-Y (2019) Shoulder pain and risk of developing hypertension and cardiovascular disease: A nationwide population-based cohort study in Taiwan. J Med Sci39, 127.
124.
DelpontB, BlancC, OssebyGV, Hervieu-BegueM, GiroudM, BejotY (2018) Pain after stroke: A review. Rev Neurol174, 671–674.
125.
TsengCH, ChenJH, WangYC, LinMC, KaoCH (2016) Increased risk of stroke in patients with fibromyalgia: A population-based cohort study. Medicine95, e2860.
126.
VellyAM, MohitS (2018) Epidemiology of pain and relation to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry87, 159–167.
127.
ShengJY, LiuS, WangYC, CuiRJ, ZhangXW (2017) The link between depression and chronic pain: Neural mechanisms in the brain. Neural Plast2017, 9724371.
128.
HarrisML (2016) Psychological factors in arthritis: Cause or consequence? In Psychosocial Factors in Arthritis: Perspectives on Adjustment and Management,
NicassioPM, ed. Springer International Publishing, pp.
53–77.
129.
KoffelE, McCurrySM, SmithMT, VitielloMV (2019) Improving pain and sleep in middle-aged and older adults: The promise of behavioral sleep interventions. Pain160, 529–534.
WuL, SunD, TanY (2018) A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders. Sleep Breath22, 805–814.
133.
de AlmondesKM, CostaMV, Malloy-DinizLF, DinizBS (2016) Insomnia and risk of dementia in older adults: Systematic review and meta-analysis. J Psychiatr Res77, 109–115.
134.
YaffeK (2018) Modifiable risk factors and prevention of dementia what is the latest evidence?JAMA Intern Med178, 281–282.
135.
CarrollS, TurkheimerE (2018) Midlife risk factors for late-life cognitive decline. Dev Rev48, 201–222.
136.
Halli-TierneyAD, ScarbroughC, CarrollD (2019) Polypharmacy: Evaluating risks and deprescribing. Am Fam Physician100, 32–38.
137.
MendittoE, Gimeno MiguelA, Moreno JusteA, Poblador PlouB, Aza Pascual-SalcedoM, OrlandoV, Gonzalez RubioF, Prados TorresA (2019) Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis. PLoS One14, e0210701.
138.
GiummarraMJ, GibsonSJ, AllenAR, PichlerAS, ArnoldCA (2015) Polypharmacy and chronic pain: Harm exposure is not all about the opioids. Pain Med16, 472–479.
139.
IvoR, NicklasA, DargelJ, SobottkeR, DelankK-S, EyselP, WeberB (2013) Brain structural and psychometric alterations in chronic low back pain. Eur Spine J22, 1958–1964.
140.
SofatN, EjinduV, KielyP (2011) What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology50, 2157–2165.
141.
JiRR, NackleyA, HuhY, TerrandoN, MaixnerW (2018) Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology129, 343–366.
142.
LluchE, TorresR, NijsJ, Van OosterwijckJ (2014) Evidence for central sensitization in patients with osteoarthritis pain: A systematic literature review. Eur J Pain18, 1367–1375.
143.
BakerKS, Georgiou-KaristianisN, GibsonSJ, GiummarraMJ (2017) Optimizing cognitive function in persons with chronic pain. Clin J Pain33, 462–472.
144.
Al-KhazrajiBK, AppletonCT, BeierF, BirminghamTB, ShoemakerJK (2018) Osteoarthritis, cerebrovascular dysfunction and the common denominator of inflammation: A narrative review. Osteoarthritis Cartilage26, 462–470.
145.
SchaibleH-G (2012) Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep14, 549–556.
146.
IkramM, InnesK, SambamoorthiU (2019) Association of osteoarthritis and pain with Alzheimer’s diseases and related dementias among older adults in the United States. Osteoarthritis Cartilage27, 1470–1480.
147.
SibilleKT, ChenH, BartleyEJ, RileyJ3rd, GloverTL, KingCD, ZhangH, Cruz-AlmeidaY, GoodinBR, SotolongoA, PetrovME, HerbertM, BullsHW, EdbergJC, StaudR, ReddenD, BradleyLA, FillingimRB (2017) Accelerated aging in adults with knee osteoarthritis pain: Consideration for frequency, intensity, time, and totalain sites. Pain Rep2, e591.
148.
HassettAL, EpelE, ClauwDJ, HarrisRE, HarteSE, KairysA, BuyskeS, WilliamsDA (2012) Pain is associated with short leukocyte telomere length in women with fibromyalgia. J Pain13, 959–969.
149.
FaniL, Hila, Saima, SedaghatS, BroerL, LicherS, ArpPP, van MeursJB, IkramMK, IkramMA (2020) Telomere length and the risk of Alzheimer’s disease: The Rotterdam Study. J Alzheimers Dis73, 707–714.
HonigLS, KangMS, SchupfN, LeeJH, MayeuxR (2012) Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol69, 1332–1339.
